M. Tachikawa

Takashi Suzuki, T. Terasaki, P. Couraud, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration.

F. Motoi, M. Unno, T. Terasaki, 2017, Journal of Pharmacy and Science.

Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.

T. Terasaki, S. Ohtsuki, Takashi Inoue, 2013, Journal of pharmaceutical sciences.

Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics.

T. Terasaki, S. Akanuma, M. Tachikawa, 2019, Drug metabolism and pharmacokinetics.

Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2019, Drug Metabolism and Disposition.

Quantitative targeted absolute proteomics of rat blood–cerebrospinal fluid barrier transporters: comparison with a human specimen

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2015, Journal of neurochemistry.

Involvement of a Novel Organic Cation Transporter in Verapamil Transport Across the Inner Blood-Retinal Barrier

Y. Kubo, S. Akanuma, M. Tachikawa, 2012, Pharmaceutical Research.

Lipophilicity and Transporter Influence on Blood-Retinal Barrier Permeability: A Comparison with Blood-Brain Barrier Permeability

S. Akanuma, M. Tachikawa, K. Hosoya, 2010, Pharmaceutical Research.

Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis.

T. Terasaki, M. Tachikawa, Yutaro Hoshi, 2016, Journal of pharmaceutical sciences.

Excitatory Amino Acid Transporter 1-Mediated L-Glutamate Transport at the Inner Blood-Retinal Barrier: Possible Role in L-Glutamate Elimination from the Retina.

Y. Kubo, S. Akanuma, M. Tachikawa, 2015, Biological & pharmaceutical bulletin.

Continuous release of O2−/ONOO−in plasma‐exposed HEPES‐buffered saline promotes TRP channel‐mediated uptake of a large cation

M. Kanzaki, H. Kanetaka, T. Kaneko, 2020 .

Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders

M. Tachikawa, K. Hosoya, 2011, Fluids and Barriers of the CNS.

Evidence for creatine biosynthesis in Müller glia

Masahiko Watanabe, T. Terasaki, M. Tomi, 2005, Glia.

The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain

Masahiko Watanabe, H. Takanaga, T. Terasaki, 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

The blood–brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters

V. Ganapathy, T. Terasaki, M. Tachikawa, 2009, Journal of neurochemistry.

Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF

Y. Kubo, S. Akanuma, M. Tachikawa, 2022, Fluids and barriers of the CNS.

Monocarboxylate transporter 12 as a guanidinoacetate efflux transporter in renal proximal tubular epithelial cells.

Y. Kubo, S. Akanuma, M. Tachikawa, 2020, Biochimica et biophysica acta. Biomembranes.

Developmental changes of l-arginine transport at the blood-brain barrier in rats.

S. Akanuma, M. Tachikawa, K. Hosoya, 2018, Microvascular research.

Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain

S. Akanuma, M. Tachikawa, K. Hosoya, 2018, Neurochemistry International.

Cell-Type-Specific Spatiotemporal Expression of Creatine Biosynthetic Enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase in Developing Mouse Brain

Masahiko Watanabe, T. Terasaki, Kazuhisa Sakai, 2018, Neurochemical Research.

γ-Aminobutyric Acid Transporter 2 Mediates the Hepatic Uptake of Guanidinoacetate, the Creatine Biosynthetic Precursor, in Rats

S. Akanuma, M. Tachikawa, K. Hosoya, 2012, PloS one.

Roles of organic anion/cation transporters at the blood–brain and blood–cerebrospinal fluid barriers involving uremic toxins

M. Tachikawa, K. Hosoya, 2011, Clinical and Experimental Nephrology.

Glycine and l-arginine transport in cultured Müller glial cells (TR-MUL)

S. Akanuma, M. Tachikawa, K. Hosoya, 2010, Neurochemistry International.

Expression and possible role of creatine transporter in the brain and at the blood‐cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant

Masahiko Watanabe, K. Sakimura, T. Terasaki, 2008, Journal of neurochemistry.

The blood‐cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter‐mediated process

T. Terasaki, K. Kitaichi, M. Tachikawa, 2008, Journal of neurochemistry.

Evidence for Creatine Biosynthesis in M

Masahiko Watanabe, T. Terasaki, M. Tomi, 2005 .

Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics.

M. Setou, T. Terasaki, S. Ohtsuki, 2017, Journal of proteomics.

Involvement of γ-aminobutyric acid transporter 2 in the hepatic uptake of taurine in rats.

S. Akanuma, M. Tachikawa, K. Hosoya, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

N. Sata, Tesshi Yamada, T. Terasaki, 2016, PloS one.

Pharmacokinetics of guanidinosuccinic acid in rat blood and cerebrospinal fluid.

Y. Kubo, S. Akanuma, M. Tachikawa, 2014, Drug metabolism and pharmacokinetics.

Brain Insulin Impairs Amyloid-β(1-40) Clearance from the Brain

T. Terasaki, S. Ohtsuki, A. Kurihara, 2004, The Journal of Neuroscience.

Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and blood-spinal cord barrier in human and rat.

T. Terasaki, Satoshi Hirano, M. Takao, 2020, Molecular pharmaceutics.

Selective Protein Expression Changes of Leukocyte-Migration-Associated Cluster of Differentiation Antigens at the Blood-Brain Barrier in a Lipopolysaccharide-Induced Systemic Inflammation Mouse Model without Alteration of Transporters, Receptors or Tight Junction-Related Protein.

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2019, Biological & pharmaceutical bulletin.

Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood–brain barrier transporters

Takashi Suzuki, T. Terasaki, P. Couraud, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Distinct transport properties of human pannexin 1 and connexin 32 hemichannels.

T. Terasaki, Yasuo Uchida, S. Akanuma, 2019, Journal of pharmaceutical sciences.

of in maintaining the

Yasuo Uchida, M. Tachikawa, Yutaro Hoshi, 2019 .

Identification of Blood-Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase.

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2018, Molecular pharmaceutics.

Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis

Takashi Suzuki, T. Terasaki, P. Couraud, 2018, Molecular Neurobiology.

Liver Zonation Index of Drug Transporter and Metabolizing Enzyme Protein Expressions in Mouse Liver Acinus

T. Terasaki, D. Saigusa, Yasuo Uchida, 2018, Drug Metabolism and Disposition.

The blood‐brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2017, Journal of neurochemistry.

Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.

A. Urtti, T. Terasaki, Satoshi Hirano, 2017, Molecular pharmaceutics.

Actin filament‐associated protein 1 (AFAP‐1) is a key mediator in inflammatory signaling‐induced rapid attenuation of intrinsic P‐gp function in human brain capillary endothelial cells

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2017, Journal of neurochemistry.

Contribution of Pannexin 1 and Connexin 43 Hemichannels to Extracellular Calcium–Dependent Transport Dynamics in Human Blood-Brain Barrier Endothelial Cells

T. Terasaki, P. Couraud, S. Ohtsuki, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Drug Transporter Protein Quantification of Immortalized Human Lung Cell Lines Derived from Tracheobronchial Epithelial Cells (Calu-3 and BEAS2-B), Bronchiolar-Alveolar Cells (NCI-H292 and NCI-H441), and Alveolar Type II-like Cells (A549) by Liquid Chromatography-Tandem Mass Spectrometry.

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2015, Journal of pharmaceutical sciences.

Fluids and Barriers of the Cns

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2022 .

Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2011, Fluids and Barriers of the CNS.

Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier.

V. Ganapathy, Pamela M. Martin, K. Murakami, 2011, Microvascular research.

Molecular-weight-dependent, anionic-substrate-preferential transport of β-lactam antibiotics via multidrug resistance-associated protein 4.

T. Terasaki, S. Ohtsuki, J. Kamiie, 2011, Drug metabolism and pharmacokinetics.

Inner blood-retinal barrier mediates l-isomer-predominant transport of serine.

T. Terasaki, S. Akanuma, M. Tachikawa, 2011, Journal of pharmaceutical sciences.

Involvement of Multidrug Resistance-Associated Protein 4 in Efflux Transport of Prostaglandin E2 across Mouse Blood-Brain Barrier and Its Inhibition by Intravenous Administration of Cephalosporins

T. Terasaki, S. Ohtsuki, S. Ito, 2010, Journal of Pharmacology and Experimental Therapeutics.

Organic anion-transporting polypeptide 1a4-mediated heterogeneous distribution of sulforhodamine-101 in rat hepatic lobules.

Y. Kubo, S. Akanuma, M. Tachikawa, 2019, Drug metabolism and pharmacokinetics.

Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier

S. Akanuma, M. Tachikawa, K. Hosoya, 2013, Fluids and Barriers of the CNS.

Hypertonicity enhances GABA uptake by cultured rat retinal capillary endothelial cells.

S. Akanuma, M. Tachikawa, K. Hosoya, 2010, Drug metabolism and pharmacokinetics.

Note Hypertonicity Enhances GABA Uptake by Cultured Rat Retinal Capillary Endothelial Cells

S. Akanuma, M. Tachikawa, K. Hosoya, 2010 .

Transporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells

Y. Kubo, S. Akanuma, M. Tachikawa, 2015, Fluids and Barriers of the CNS.

ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-β peptide (1–40) at the blood–brain barrier

T. Iwatsubo, T. Terasaki, K. Ueda, 2008, Neurochemistry International.

Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells.

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2016, Journal of pharmaceutical sciences.

Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2016 .

Co-localization of microsomal prostaglandin E synthase-1 with cyclooxygenase-1 in layer II of murine placental syncytiotrophoblasts.

T. Nakanishi, I. Tamai, T. Nishimura, 2017, Placenta.

Distribution of microsomal prostaglandin E synthase‐1 in the mouse brain

A. Blomqvist, M. Tachikawa, K. Hosoya, 2014, The Journal of comparative neurology.

Involvement of cationic amino acid transporter 1 in L-arginine transport in rat retinal pericytes.

S. Akanuma, M. Tachikawa, K. Hosoya, 2015, Biological & pharmaceutical bulletin.

Up-regulation of L-type amino acid transporter 1 (LAT1) in cultured rat retinal capillary endothelial cells in response to glucose deprivation.

Y. Kubo, M. Tomi, S. Akanuma, 2012, Drug metabolism and pharmacokinetics.

Retinal‐specific ATP‐binding cassette transporter (ABCR/ABCA4) is expressed at the choroid plexus in rat brain

T. Terasaki, S. Ohtsuki, S. Hori, 2005, Journal of neurochemistry.

Blood-to-retina transport of biotin via Na+-dependent multivitamin transporter (SMVT) at the inner blood-retinal barrier.

S. Akanuma, M. Tachikawa, K. Hosoya, 2010, Experimental eye research.

Involvement of a Novel Organic Cation Transporter in Verapamil Transport Across the Inner Blood-Retinal Barrier

Y. Kubo, S. Akanuma, M. Tachikawa, 2013, Pharmaceutical Research.

Inner Blood-Retinal Barrier Transporters: Role of Retinal Drug Delivery

M. Tachikawa, K. Hosoya, 2009, Pharmaceutical Research.

Dehydroascorbic acid uptake and intracellular ascorbic acid accumulation in cultured Müller glial cells (TR-MUL)

M. Tomi, S. Akanuma, M. Tachikawa, 2008, Neurochemistry International.

Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (σR1).

E. Zorrilla, V. Ganapathy, K. Bollinger, 2011, Investigative ophthalmology & visual science.

Quantitative expression of human drug transporter proteins in lung tissues: analysis of regional, gender, and interindividual differences by liquid chromatography-tandem mass spectrometry.

Tetsuya Terasaki, Yasuo Uchida, Sumio Ohtsuki, 2013, Journal of pharmaceutical sciences.

Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.

T. Terasaki, Takahiro Tanaka, T. Nishimura, 2019, Journal of pharmaceutical sciences.

Targeted proteomics-based quantitative protein atlas of pannexin and connexin subtypes in mouse and human tissues and cancer cell lines.

T. Terasaki, H. Ohtsuka, S. Ohtsuki, 2020, Journal of pharmaceutical sciences.

The Multipotential of Leucine-Rich α-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.

K. Ohshima, T. Terasaki, M. Morioka, 2020, Journal of neuropathology and experimental neurology.

Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

T. Terasaki, S. Ohtsuki, M. Nakada, 2018, PloS one.

Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.

K. Brouwer, T. Terasaki, J. Nicolazzo, 2018, Molecular pharmaceutics.

Gene expression of A6-like subgroup of ATP-binding cassette transporters in mouse brain parenchyma and microvessels

Masahiko Watanabe, T. Terasaki, M. Tomi, 2018, Anatomical Science International.

MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Stellate Cells

F. Motoi, M. Unno, T. Terasaki, 2017, Pancreas.

Function and regulation of taurine transport in Müller cells under osmotic stress

Y. Kubo, S. Akanuma, M. Tachikawa, 2012, Neurochemistry International.

Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.

T. Terasaki, P. Couraud, S. Ohtsuki, 2013, Molecular pharmaceutics.

Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport

T. Terasaki, M. W. Sadiq, M. Hammarlund-Udenaes, 2015, PloS one.

Quantitative targeted proteomics for understanding the blood–brain barrier: towards pharmacoproteomics

T. Terasaki, S. Ohtsuki, S. Ito, 2014, Expert review of proteomics.

Amyloid beta25‐35 impairs docosahexaenoic acid efflux by down‐regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells

T. Terasaki, P. Couraud, Yasuo Uchida, 2019, Journal of neurochemistry.

Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2014 .

Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.

T. Terasaki, M. Tachikawa, K. Hosoya, 2014, Advances in pharmacology.

Role of the blood–cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E2 produced in the brain

S. Akanuma, M. Tachikawa, K. Hosoya, 2012, Journal of neurochemistry.

A Clearance System for Prostaglandin D2, a Sleep-Promoting Factor, in Cerebrospinal Fluid: Role of the Blood-Cerebrospinal Barrier Transporters

K. Hayashi, A. Nishiura, S. Akanuma, 2012, Journal of Pharmacology and Experimental Therapeutics.

The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells*

D. Holtzman, T. Iwatsubo, G. Bu, 2008, Journal of Biological Chemistry.

Multiple Cellular Transport and Binding Processes of Unesterified Docosahexaenoic Acid in Outer Blood-Retinal Barrier Retinal Pigment Epithelial Cells.

Y. Hatanaka, S. Akanuma, M. Tachikawa, 2018, Biological & pharmaceutical bulletin.

24S‐hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical‐ and apoE isoform‐dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression

T. Terasaki, S. Ohtsuki, Masachika Fujiyoshi, 2007, Journal of neurochemistry.

Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells.

T. Terasaki, S. Ohtsuki, S. Ito, 2013, Journal of Alzheimer's disease : JAD.

Brain insulin impairs amyloid-beta(1-40) clearance from the brain.

T. Terasaki, S. Ohtsuki, A. Kurihara, 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plasma for pancreatic cancer diagnosis.

T. Terasaki, S. Ohtsuki, M. Ono, 2013, Journal of proteome research.

A novel relationship between creatine transport at the blood-brain and blood-retinal barriers, creatine biosynthesis, and its use for brain and retinal energy homeostasis.

T. Terasaki, S. Ohtsuki, M. Tachikawa, 2007, Sub-cellular biochemistry.

Na+-Independent Choline Transport in Rat Retinal Capillary Endothelial Cells

M. Tomi, M. Tachikawa, K. Hosoya, 2007, Neurochemical Research.

Polarized hemichannel opening of pannexin 1/connexin 43 contributes to dysregulation of transport function in blood-brain barrier endothelial cells

T. Terasaki, K. Murakami, S. Akanuma, 2019, Neurochemistry International.

Transport systems of serine at the brain barriers and in brain parenchymal cells

S. Akanuma, M. Tachikawa, K. Hosoya, 2011, Journal of neurochemistry.

ATF4-mediated transcriptional regulation protects against β-cell loss during endoplasmic reticulum stress in a mouse model

K. Tsuboi, Y. Okamoto, S. Oyadomari, 2021, Molecular metabolism.

All‐trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC‐1 by up‐regulating protein expression of deoxycytidine kinase

M. Unno, T. Terasaki, H. Ohtsuka, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Transporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells

Y. Kubo, S. Akanuma, M. Tachikawa, 2015, Fluids and Barriers of the CNS.

Blood–Brain Barrier (BBB) Pharmacoproteomics: A New Research Field Opened Up by Quantitative Targeted Absolute Proteomics (QTAP)

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2014 .

Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.

A. Urtti, T. Terasaki, M. Reinisalo, 2019, Investigative ophthalmology & visual science.

Scrambled Internal Standard Method for High-Throughput Protein Quantification by Matrix-Assisted Laser Desorption Ionization Tandem Mass Spectrometry.

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2017, Journal of proteome research.

A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2013, Fluids and Barriers of the CNS.

Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier

S. Akanuma, M. Tachikawa, K. Hosoya, 2013, Fluids and Barriers of the CNS.

The inner blood-retinal barrier: molecular structure and transport biology.

M. Tachikawa, K. Hosoya, 2012, Advances in experimental medicine and biology.

Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.

J. Oppert, T. Terasaki, J. Bouillot, 2016, Molecular pharmaceutics.

Na+-independent nucleoside transporters regulate adenosine and hypoxanthine levels in Müller cells and the inner blood-retinal barrier.

Y. Kubo, S. Akanuma, M. Tachikawa, 2013, Investigative ophthalmology & visual science.

ATP-Binding Cassette Transporter A Subfamily 8 Is a Sinusoidal Efflux Transporter for Cholesterol and Taurocholate in Mouse and Human Liver.

T. Terasaki, S. Ohtsuki, Satoshi Hirano, 2018, Molecular pharmaceutics.

Amyloid‐β peptide(1‐40) elimination from cerebrospinal fluid involves low‐density lipoprotein receptor‐related protein 1 at the blood‐cerebrospinal fluid barrier

T. Iwatsubo, T. Terasaki, S. Ohtsuki, 2011, Journal of neurochemistry.

SLC6A and SLC16A family of transporters: Contribution to transport of creatine and creatine precursors in creatine biosynthesis and distribution.

S. Akanuma, M. Tachikawa, K. Hosoya, 2021, Biochimica et biophysica acta. Biomembranes.

Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases

J. Sydor, T. Terasaki, G. Fricker, 2015, Pharmaceutical Research.

Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis

T. Terasaki, P. Couraud, S. Ohtsuki, 2018, Molecular Neurobiology.

Transporter-mediated prostaglandin E₂ elimination across the rat blood-brain barrier and its attenuation by the activation of N-methyl-D-aspartate receptors.

Y. Kubo, S. Akanuma, M. Tachikawa, 2014, Drug metabolism and pharmacokinetics.

Characteristics of glycine transport across the inner blood–retinal barrier

S. Akanuma, M. Tachikawa, K. Hosoya, 2009, Neurochemistry International.

Assembly of Taurine Transporter (Slc6a6) with Na+-H+ Exchanger Regulatory Factor 1 (Slc9a3r1) Improves GABA Transport Activity by Increasing the Maximum Transport Velocity.

S. Akanuma, M. Tachikawa, K. Hosoya, 2018, Biological & pharmaceutical bulletin.

Quantitative targeted absolute proteomics (QTAP)-based rational research on the human blood-brain barrier transport

T. Terasaki, Yasuo Uchida, M. Tachikawa, 2013 .

Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine.

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2016, Molecular pharmaceutics.

Determination of Intrinsic Creatine Transporter (Slc6a8) Activity and Creatine Transport Function of Leukocytes in Rats.

T. Terasaki, M. Tachikawa, K. Hosoya, 2020, Biological & pharmaceutical bulletin.

Contribution of Prostaglandin Transporter OATP2A1/SLCO2A1 to Placenta-to-Maternal Hormone Signaling and Labor Induction

T. Nakanishi, I. Tamai, T. Nishimura, 2020, iScience.

Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.

T. Terasaki, M. Tachikawa, Zhengyu Zhang, 2019, Molecular pharmaceutics.

Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

N. Sata, T. Terasaki, S. Fujita, 2016, PloS one.

Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders

M. Tachikawa, K. Hosoya, 2011, Fluids and Barriers of the CNS.

Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms

M. Perera, M. T. Lee, M. G. Scordo, 2016, The Pharmacogenomics Journal.

High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.

T. Terasaki, S. Ohtsuki, Yasuo Uchida, 2018, Molecular pharmaceutics.

Increased Expression of Renal Drug Transporters in a Mouse Model of Familial Alzheimer's Disease.

K. Brouwer, T. Terasaki, J. Nicolazzo, 2019, Journal of pharmaceutical sciences.

Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood–retinal barrier

M. Tomi, M. Tachikawa, K. Hosoya, 2011, Expert opinion on drug delivery.

Involvement of Multidrug Resistance-Associated Protein 4 in Efflux Transport of Prostaglandin E2 across Mouse Blood-Brain Barrier and Its Inhibition by Intravenous Administration of Cephalosporins

T. Terasaki, S. Ohtsuki, S. Ito, 2010, Journal of Pharmacology and Experimental Therapeutics.

LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.

A. Urtti, T. Terasaki, Laura Pelkonen, 2017, Molecular pharmaceutics.

Abnormal N-Glycosylation of a Novel Missense Creatine Transporter Mutant, G561R, Associated with Cerebral Creatine Deficiency Syndromes Alters Transporter Activity and Localization.

T. Terasaki, S. Ohtsuki, S. Ito, 2017, Biological & pharmaceutical bulletin.